Disease: Acute SARS-CoV-2

COCOPREV

France
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Basoulis

Greece
|
2022-2023
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Nirmatrelvir/Ritonavir

De Vito

Italy
|
2022-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Molnupiravir

Drysdale

Belgium
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Paediatric
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab

Patel

United Kingdom
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Paediatric
  • Primary care
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Nirmatrelvir/Ritonavir
  • Sotrovimab
  • Molnupiravir

Entrenas-Castillo

Spain
|
2020-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Steroids
  • Vitamin D

PANTHER

United Kingdom
|
2024
  • Adults
  • General population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza
  • Pharmacological intervention
  • Immnunomodulator
  • Baricitinib
  • Statins
  • Simvastatin

EU-PROACT

France Norway Spain Belgium Italy United Kingdom Ireland Austria The Netherlands Switzerland
|
2025
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza

ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
|
2024
  • Adults
  • Primary care
  • Community
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray

ECRAID-REMAP-CAP

Belgium Croatia Czech Republic Estonia France Germany Hungary Ireland Italy The Netherlands Portugal Serbia Slovenia Spain Switzerland United Kingdom
|
2018
  • Adults
  • Paediatric
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Post-COVID-19
  • Acute SARS-CoV-2
  • Avian Influenza
  • Influenza
  • Pharmacological intervention
  • Immnunomodulator
  • Corticosteroid
  • Baloxavir
  • Oseltamivir

REACT

Spain Denmark South Africa
|
2022-2026
  • Adults
  • Hospital wide
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Influenza
  • Blood sample
  • PBMC
  • Serum
  • Whole blood
  • Plasma

ADEQUATE

Serbia Belgium
|
2021-2025
  • Adults
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Syndromic diagnostic testing